Search results
CRYOcheck Pooled Normal Plasma, frozen
Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.
CRYOcheck Pooled Normal Plasma, frozen
Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.
BIOPHEN Normal Plasma (Poolplasma, non-titrated)
Non-titrated quality control human citrated plasma for coagulation assays. Dilution plasma for the assay of lupus anticoagulant (LA) with usual laboratory methods.
BIOPHEN DTI (Direct Thrombin Inhibitors)
Assay proposed for the measurement of anti-IIa activity in research applications.
ZYMUTEST TAFI (Activatable)
Assay proposed for the measurement of TAFI in research applications.
HEMOCLOT DTI 2.5 (Direct Thrombin Inhibitors)
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.
HEMOCLOT DTI 1 (Direct Thrombin Inhibitors)
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.
HEMOCLOT Quanti. V-L
Quantitative measurement of Factor V Leiden, resistant to the action of activated protein C (APC resistance), for diagnosing patients carrying the R506Q FV mutation (Factor V Leiden), or any FV mutant resistant to APC.
CEPHEN APTT 5
Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.
CEPHEN APTT 2.5
Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.